Genencor, a US division of Denmark's Danisco, has launched the first ever commercially available enzyme product for cellulosic ethanol, Accellerase 1000, at the Cellulosic Ethanol Summit in Washington, DC. Accellerase 1000 has been developed specifically for second generation biorefineries, and contains a complex of enzymes that reduce lignocellulosic biomass into fermentable sugars – a necessary step for the production of cellulosic ethanol.
Tom Knutzen, managing director of Danisco says: "The product we are launching is targeted at all those who make laboratory tests and plan to make pilot plants, so it is very development-oriented. Initially, it is more important for many to use it, rather than achieving large volumes. In a financial sense, it is not a major product in the short term."
Accellerase is the first of what Genencor expects to be a family of products tailored to different biomass feedstock and system conditions. The key features that are expected to be important at commercial scale are already built into the product, the company writes in a press release.
Danisco was founded in 1989 and is headquartered in Copenhagen. The company employs 9,700 people and has an international presence in 47 countries. Danisco is listed on the Copenhagen Stock Exchange.
Genencor is a leader in the industrial biotechnology sector and employs 1,500 people. The company is headquartered in Rochester, New York, and has R&D activities at its location in Palo Alto, California.
The news was reported by financial daily newspaper Børsen and on Danisco's website.